Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Health
Matt Emma

Rapamycin: Where Science Ends and the Promises Begin

Rapamycin has become one of the most talked-about compounds in longevity research. Over the past decade, it has moved from a niche topic in molecular biology into mainstream discussions about healthy aging. Some describe it as one of the most promising discoveries in longevity science, while others see it as another overhyped anti-aging trend. The truth lies somewhere in between.

Unlike many compounds promoted in the longevity space, rapamycin is backed by decades of research and a well-understood biological mechanism, but promising science is not the same as proven medicine.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.